{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:49:19Z","timestamp":1782928159118,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ad.2026.104630","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:17:23Z","timestamp":1773854243000},"page":"104630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world Evidence of Baricitinib in Severe Alopecia Areata: Insights From a Spanish Case Series"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0640-2200","authenticated-orcid":false,"given":"A.","family":"Alcal\u00e1 Ram\u00edrez del Puerto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Conejo-Mir S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Barabash-Neila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2026.104630_bib0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/jcm12030964","article-title":"Systematic review of psychological interventions for quality of life, mental health, and hair growth in alopecia areata and scarring alopecia","volume":"12","author":"Maloh","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ad.2026.104630_bib0060","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2026.104630_bib0065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/bjd\/ljad253","article-title":"When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials","volume":"189","author":"King","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2026.104630_bib0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/jdv.20312","article-title":"Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: a 24-week Italian study","volume":"39","author":"Piraccini","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104630_bib0075","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2268764","article-title":"Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience","volume":"34","author":"Gargiulo","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2026.104630_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/actadv.v104.18348","article-title":"Baricitinib therapy for moderate to severe alopecia areata: a retrospective review of 95 Japanese patients","volume":"104","author":"Numata","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2026.104630_bib0085","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1402a73","article-title":"Real-world experience of tofacitinib and baricitinib use in alopecia areata in Greek population: a retrospective analysis with focus on safety","volume":"14","author":"Apalla","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.ad.2026.104630_bib0090","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaad.2023.09.089","article-title":"Baricitinib for the treatment of alopecia areata in adults: real-world analysis of 36 patients","volume":"90","author":"Moreno-V\u00edlchez","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104630_bib0095","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jocd.16123","article-title":"Effectiveness and safety of baricitinib in patients with moderate-to-severe refractory alopecia areata in real world: an open-label, single-center study","volume":"23","author":"Bi","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104630_bib0100","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s13555-023-01030-x","article-title":"Real-life effectiveness and tolerance of baricitinib for the treatment of severe alopecia areata with 1-year follow-up data","volume":"13","author":"De Greef","year":"2023","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:16:20Z","timestamp":1782926180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731026000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001731026000402"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2026.104630","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world Evidence of Baricitinib in Severe Alopecia Areata: Insights From a Spanish Case Series","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2026.104630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104630"}}